SUMMARY Breast size and milk secretion was studied in term and preterm infants. Breast nodules were palpable in most of the mature infants, both boys and girls. In 6 term infants without palpable breast tissue there was a high incidence of complications during late pregnancy or delivery. In light-for-gestational age infants the breast diameter was generally appropriate for gestation. None of the infants under 31 weeks' gestation had palpable breast tissue at birth, but some in the first weeks of life developed breast tissue and secreted milk. Milk had been secreted by most of the mature infants by age 7 days, and the onset was earlier in light-for-dates infants. The breast does not regress rapidly after birth. The nodules persist into the second half of the first year by which time sex differences have emerged. Clearly the growth and activity of the neonatal breast cannot be explained solely in terms of the influence of maternal hormones towards the end of gestation. Further studies on early breast tissue development may indicate the other endocrine factors concerned.
Breast nodules are present in most newborn infants, boys and girls alike, and towards the end of the first week of life, gentle palpation of the nodules generally results in the release of milk. Histological studies have demonstrated that the nodules are formed of well developed breast tissue with lacteals, acini, and actively secreting alveolar cells.1 2 Biochemical analyses of the secretion have shown that it contains carbohydrate, proteins, and fats, and it has been suggested that it is similar to first milk in mothers.2 3 Detailed analyses have not been made. There is evidence that oestrogens, progesterone and mammotropic peptides, including prolactin and human placental lactogen, take part in the growth and development of breast tissue during pregnancy. 4 However there is uncertainty about the extent that hormones, which act on the maternal tissues and are present in the maternal circulation, are responsible for the breast development in the newborn infant. The failure of many preterm infants to develop breast nodules or secrete milk after birth, indicates the importance of the intrauterine environment. On the other hand, the fetus itself produces a variety of hormones which may influence breast developmentfor example prolactin levels in the infant's blood are high at birth and in the succeeding days.5
If the fetal breast tissue is the end organ of oestrogen, progesterone, and prolactin activity, its size and behaviour after birth may provide interesting information on the differences in endocrine environment experienced by the infants before birth. The natural history of breast tissue growth and milk release in the first year of life was examined in normal, healthy, and mature infants and compared with that of the small, preterm infant. The clinical features of infants who did not have breast tissue at birth are also reported.
Methods
The diameter of the breast nodule was measured by comparing the diameter of the palpable breast tissue with discs of standard size. Both breasts were measured and the results reported as the average of the two. All the measurements were made by one - There was no difference between the sexes. Fifteen infants without palpable nodules had been born preterm but 6 had not, and these 6 had had a surprising incidence of problems during late pregnancy and delivery (Table) . Sometimes mothers after their first pregnancy have difficulty establishing breast feeding, and milk comes more easily with second and subsequent pregnancies; however there was no significant difference between breast diameter in infants of first or subsequent pregnancies. It might have been expected that breast tissue being inessential, would be undersized in the undernourished newborn infant. That is certainly not so. Indeed the breast appears to grow according to gestation rather than according to body size (Fig. 2) . 
The time in gestation when breast tissue becomes palpable varies greatly. It was found in some infants under 32 weeks' gestation, but was not palpable in one-third of infants of 36 weeks' gestation (Fig. 3) In 23 preterm infants who did not have breast nodules at birth, breast tissue became palpable in over 40% of them during the first 9 weeks of life, although none developed large nodules of the size that are found in term newborn infants. In healthy mature infants, the diameter of the breast increased during the first 2 weeks of life after which it decreased to an average of about 10 mm (Fig. 4) where it remained until about 4-6 months of age. By this time there was a difference between boys and girls which was even more apparent by age 10 months (Fig. 5) .
Milk secretion. In most mature term infants milk secretion first appeared between the 5th and 7th days of life. The onset of secretion was earlier in the infants who were LGA (Fig. 6) nodule at different gestational ages.10 11 Indeed breast size is an item in some programmes for assessment of gestation.'2 However, the histological development of the human breast does not relate well to gestational age,' and the wide variations which we and others have found make it a poor guide to maturity.
There have been few studies on the growth of the breast after birth. The increase in size during the first 2 weeks of life can probably be ascribed to engorgement with secretion, for the neonatal breast is not 'milked'. Lactation is therefore inhibited; if the breast is regularly massaged, milk secretion continues.' 213 Contrary to some statements,' '6 breast tissue does not immediately involute after birth; it is easily palpable in many infants of both sexes during the first 6 months of life. The breast nodule, on average, is larger and persists in girls. This finding is contrary to that reported by Nachtigall,'7 who concluded that breast gland swellings disappeared in the 3rd month of life and that gender made no difference. The occasional failure of regression of breast nodules during the first year of life has been commented on by clinicians,'8 and confirmed by histological studies.8 19 The pattern of persisting breast development we have described is in accord with current views on the secretion of gonadotrophins and oestrogens in infancy.'9
The failure of some preterm infants to develop breast tissue or to lactate in the neonatal period led some clinicians to give such infants gonadotrophic hormones and oestrogens. Initial reports were optimistic, but controlled trials were unable to sustain the evidence of benefit.7 However careful study shows that in some preterm infants breast tissue does develop after birth, presumably under the influence of the infant's own oestrogenic secretions and independently of the feto-placental unit. The onset of milk secretion in some of these infants took place long after the progesterone withdrawal,20 which might be expected to occur at the time of birth in mother and infant.
Lactation in the mother requires a high level of circulating prolactin.2' In the mature infant prolactin levels are high at birth and decrease during the subsequent weeks.5 In immature infants prolactin levels remain higher for longer (unpublished observations). The fact that many LGA infants secrete milk in the first 3 days of life suggests that they have been subject to 'progesterone withdrawal' earlier than AGA infants.
Six infants at 38 weeks' gestation or greater, of good birthweights, had no breast nodules. Most of these infants had some complication in the perinatal period suggesting that despite their apparent maturity, they were ill-prepared for delivery. Until we know more about the endocrine factors which control the growth and development of the fetal breast in physiological conditions, it is difficult to interpret the variation that occurs with disorder.
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